Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis …

C Comarmond, C Pagnoux, M Khellaf… - Arthritis & …, 2013 - Wiley Online Library
Objective Earlier studies of eosinophilic granulomatosis with polyangiitis (Churg‐Strauss) (EGPA),
with limited patient numbers and followup durations, demonstrated that clinical …

Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment

C Comarmond, P Cacoub - Autoimmunity reviews, 2014 - Elsevier
Granulomatosis with polyangiitis (GPA) is a systemic necrotizing vasculitis, which affects
small- and medium-sized blood vessels and is often associated with cytoplasmic ANCA. GPA …

Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients

A Mekinian, C Comarmond, M Resche-Rigon… - Circulation, 2015 - Am Heart Assoc
Background— The goal of this work was to assess the safety and efficacy of biologics (ie,
tumor necrosis factor-α antagonists and tocilizumab) in patients with Takayasu arteritis. …

Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients

C Comarmond, L Biard, M Lambert, A Mekinian… - Circulation, 2017 - Am Heart Assoc
Background: Because of the wide variation in the course of Takayasu arteritis (TA), predicting
outcome is challenging. We assess long-term outcome and prognosis factors for vascular …

Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature

C Comarmond, E Plaisier, K Dahan, T Mirault… - Autoimmunity …, 2012 - Elsevier
Takayasu arteritis (TA) is a rare large vessels vasculitis. Conventional therapy consists of
glucocorticoids which may be associated with other immunosuppressive drugs. However, …

Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis

…, SNS Ahmed, L de Saint Martin, C Comarmond… - Gastroenterology, 2017 - Elsevier
Circulating mixed cryoglobulins are detected in 40%–60% of patients with hepatitis C virus (HCV)
infection, and overt cryoglobulinemia vasculitis (CryoVas) develops in approximately …

Extrahepatic manifestations of chronic hepatitis C virus infection

P Cacoub, C Comarmond, F Domont… - Therapeutic …, 2016 - journals.sagepub.com
During hepatitis C virus (HCV) chronic infection, extrahepatic manifestations are frequent
and polymorphous. This article reports on a large cohort of patients with HCV-related …

Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus–induced cryoglobulinemia vasculitis

C Comarmond, M Garrido, S Pol, AC Desbois… - Gastroenterology, 2017 - Elsevier
Background & Aims Interferon-free direct-acting antiviral (DAA) therapies are effective in
patients with hepatitis C virus–induced cryoglobulinemia vasculitis (HCV-CV). We analyzed …

Overall survival and mortality risk factors in Takayasu's arteritis: a multicenter study of 318 patients

A Mirouse, L Biard, C Comarmond, M Lambert… - Journal of …, 2019 - Elsevier
Objective To report the long term mortality in Takayasu arteritis (TA) and to identify prognosis
factors. Methods We analyzed the causes of death and the factors associated with mortality …

Targeting JAK/STAT pathway in Takayasu's arteritis

…, AC Desbois, C Comarmond… - Annals of the …, 2020 - ard.bmj.com
Objective Takayasu’s arteritis (TAK) is a large vessel vasculitis with important infiltration of
proinflammatory T cells in the aorta and its main branches, but its aetiology is still unknown. …